Disease | hematopoietic stem cell transplantation |
Phenotype | C0023448|lymphocytic leukemia |
Sentences | 3 |
PubMedID- 23435461 | The purpose of this analysis was to provide 6-year follow-up of the cll3x trial, which studied reduced-intensity allogeneic hematopoietic stem cell transplantation (hsct) in patients with poor-risk chronic lymphocytic leukemia (cll), and to investigate the effect of tp53, sf3b1, and notch1 mutations on hsct outcome. |
PubMedID- 23014659 | Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia. |
PubMedID- 22116553 | hematopoietic stem cell transplantation in t-prolymphocytic leukemia: a retrospective study from the european group for blood and marrow transplantation and the royal marsden consortium. |
Page: 1